Over the last 12 months, Heartflow insiders reported no purchases and 4 sales totaling $2.9M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Rogers CampbellChief Medical Officer · O | ▼ Sale | 9,219 | $25.72 | $237K | -9.4% | plan |
| Jul 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $27.75 | $626K | -4.9% | plan |
| Jun 24, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 38,900 | $35 | $1.4M | -7.8% | plan |
| Jun 10, 2026 | Farquhar John C.M.Chief Executive Officer · O·D | ▼ Sale | 22,562 | $28.5 | $643K | -4.3% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $HTFL feed.